Scarica l'app Stockscreener
19.73
2.86%
-0.58
Dopo l'orario di chiusura:
19.62
-0.11
-0.56%
Acadia Pharmaceuticals Inc Azioni (ACAD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.88%
307.96
|
268.06 | 283.99 | 278.63 | 264.57 |
| Cost Of Revenue |
14.22%
28.32
|
24.79 | 26.23 | 21.65 | 20.73 |
Selling, General, and Administrative
|
6.30%
160.25
|
171.02 | - | - | - |
| Costs And Expenses |
0.94%
270.12
|
272.68 | 266.60 | 242.88 | 232.19 |
| Operating Income/Loss |
919.67%
37.84
|
-4.616 | 17.39 | 35.76 | 32.37 |
| Income/Loss From Continuing Operations Before Tax |
1,067%
46.47
|
3.981 | 26.32 | 44.59 | 40.21 |
| Income Tax Expense/Benefit |
4,253%
14.97
|
0.344 | -247.25 | -27.18 | 13.54 |
|
Net Income/Loss
|
766.10%
31.50
|
3.637 | 273.57 | 71.78 | 26.67 |
| Basic Average Shares |
0.64%
171.60
|
170.52 | 0.519 | 168.84 | 167.83 |
| Diluted Average Shares |
0.08%
172.85
|
172.71 | 0.763 | 170.65 | 168.68 |
| Basic Earnings Per Share |
800.00%
0.18
|
0.02 | 1.62 | 0.43 | 0.16 |
| Diluted Earnings Per Share |
800.00%
0.18
|
0.02 | 1.61 | 0.42 | 0.16 |
3.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):